Just Healthcare

Just Healthcare

FDA Rethinks Phenylephrine Cold Remedies Effectiveness

Regulators move to phase out oral phenylephrine, citing lack of effectiveness against nasal congestion.

Naveen Sankar S's avatar
Naveen Sankar S
Dec 27, 2024
∙ Paid
A professional medical illustration focusing on the FDA's decision to phase out oral phenylephrine in cold medications due to ineffectiveness. The image features a clean, modern design with symbolic representations of nasal congestion, such as a simplified nasal passage diagram and medication capsules. Visual elements include a comparison of oral phenylephrine pills versus nasal sprays, emphasizing the effectiveness of sprays. Icons representing scientific research, such as magnifying glasses and molecular structures, add clarity. The color palette is calming and professional, with shades of blue and white, creating an approachable and informative style.

Topline:

The FDA plans to phase out oral phenylephrine, a common ingredient in cold medicines, after concluding it is ineffective for nasal congestion relief.

Study Details:

Phenylephrine, found in popular over-the-counter medications like Sudafed PE and DayQuil, has been a go-to remedy for nasal congestion for years. However, concerns about its effectiven…

User's avatar

Continue reading this post for free, courtesy of Naveen Sankar S.

Or purchase a paid subscription.
© 2026 Just Healthcare · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture